GE ends Immelt era with another earnings beat, stock pullback >>> READ MORE

ARNA

Recent Articles

3 Stocks to Watch on Tuesday: Snap Inc (SNAP), Barracuda Networks Inc (CUDA) and Arena Pharmaceuticals, Inc. (ARNA)

Snap (SNAP) continues slumping below its IPO price Tuesday and Arena Pharmaceuticals (ARNA) rockets ahead on trial data, while Barracuda Networks (CUDA) slides on earnings. More 

5 Reasons Why VIVUS, Inc. (VVUS) Stock Should Be in Your Portfolio

VIVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies. Here's why VVUS stock is a must More 

3 Stocks to Watch on Wednesday: Bank of America Corp (BAC), Arena Pharmaceuticals, Inc. (ARNA) and Fogo De Chao Inc (FOGO)

Bank of America (BAC) anxiously awaits a Fed decision on Wednesday, Arena Pharmaceuticals (ARNA) rockets higher and Fogo de Chao (FOGO) carves out some gains. More 

26 Biotechnology Stocks to Sell Now

The ratings of 26 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

23 Biotechnology Stocks to Sell Now

The overall ratings of 23 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

22 Biotechnology Stocks to Sell Now

This week, 22 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

19 Biotechnology Stocks to Sell Now

The overall ratings of 19 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More